Physician profile
Stephen John Ronan
NPI 1649239971
$2,996.24
in general payments reported to CMS, 2019-2025
12 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $348 · 2021: $464 · 2022: $205 · 2023: $253 · 2024: $804 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,130.31 | 2019-2025 | Dysport |
| Mentor Worldwide LLC | $582.29 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Revance Therapeutics, INC. | $293.80 | 2024 | Daxxify |
| Allergan, INC. | $262.12 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $223.26 | 2019 | |
| Motiva USA, LLC | $176.31 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $149.92 | 2019 | |
| Sientra, INC. | $51.61 | 2021 | |
| Lilly USA, LLC | $49.94 | 2019-2020 | |
| Merz North America, INC. | $41.34 | 2024 | |
| Next Science LLC | $19.79 | 2020 | |
| Zyla Life Sciences, INC. | $15.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ronan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.